Calamos Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-27,075
Closed -$659K – 717
2015
Q1
$659K Hold
27,075
– – ﹤0.01% 569
2014
Q4
$602K Hold
27,075
– – ﹤0.01% 587
2014
Q3
$684K Sell
27,075
-5,300
-16% -$147K ﹤0.01% 553
2014
Q2
$893K Hold
32,375
– – 0.01% 531
2014
Q1
$947K Buy
32,375
+375
+1% +$10.1K 0.01% 513
2013
Q4
$825K Buy
32,000
+2,400
+8% +$59.9K 0.01% 523
2013
Q3
$711K Buy
29,600
+11,800
+66% +$295K ﹤0.01% 507
2013
Q2
$375K Buy
+17,800
New +$384K ﹤0.01% 554

Other funds holding TBI

Calamos Advisors's TBI Position: Q2 2015 in Review

Calamos Advisors sold out of Trueblue (TBI) in Q2 2015, closing a stake of 27,075 shares — an estimated $659K sold.

Calamos Advisors first reported a position in TBI in Q2 2013 and held it in 8 quarters. The position peaked at $947K in Q1 2014. 170 funds tracked by Wall St. Rank hold TBI as of Q2 2015.

  • Calamos Advisors reported no remaining Trueblue position as of Q2 2015 after selling out during the quarter.
  • Calamos Advisors sold 27,075 Trueblue shares in Q2 2015, an estimated $659K.
  • Calamos Advisors first reported a position in Trueblue in Q2 2013 and held it in 8 quarters.
  • Calamos Advisors's Trueblue position peaked at $947K in Q1 2014.
  • 170 funds tracked by Wall St. Rank held Trueblue as of Q2 2015.

Based on Calamos Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.